Anti-TSC2 monoclonal antibody

Pre-made anti-TSC2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TSC2/TSC2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2180-Ab-1/ GM-Tg-hg-IP2180-Ab-2Anti-Human TSC2 monoclonal antibodyHuman
GM-Tg-rg-IP2180-Ab-1/ GM-Tg-rg-IP2180-Ab-2Anti-Rat TSC2 monoclonal antibodyRat
GM-Tg-mg-IP2180-Ab-1/ GM-Tg-mg-IP2180-Ab-2Anti-Mouse TSC2 monoclonal antibodyMouse
GM-Tg-cynog-IP2180-Ab-1/ GM-Tg-cynog-IP2180-Ab-2Anti-Cynomolgus/ Rhesus macaque TSC2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2180-Ab-1/ GM-Tg-felg-IP2180-Ab-2Anti-Feline TSC2 monoclonal antibodyFeline
GM-Tg-cang-IP2180-Ab-1/ GM-Tg-cang-IP2180-Ab-2Anti-Canine TSC2 monoclonal antibodyCanine
GM-Tg-bovg-IP2180-Ab-1/ GM-Tg-bovg-IP2180-Ab-2Anti-Bovine TSC2 monoclonal antibodyBovine
GM-Tg-equg-IP2180-Ab-1/ GM-Tg-equg-IP2180-Ab-2Anti-Equine TSC2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2180-Ab-1/ GM-Tg-hg-IP2180-Ab-2; GM-Tg-rg-IP2180-Ab-1/ GM-Tg-rg-IP2180-Ab-2;
GM-Tg-mg-IP2180-Ab-1/ GM-Tg-mg-IP2180-Ab-2; GM-Tg-cynog-IP2180-Ab-1/ GM-Tg-cynog-IP2180-Ab-2;
GM-Tg-felg-IP2180-Ab-1/ GM-Tg-felg-IP2180-Ab-2; GM-Tg-cang-IP2180-Ab-1/ GM-Tg-cang-IP2180-Ab-2;
GM-Tg-bovg-IP2180-Ab-1/ GM-Tg-bovg-IP2180-Ab-2; GM-Tg-equg-IP2180-Ab-1/ GM-Tg-equg-IP2180-Ab-2
Products NameAnti-TSC2 monoclonal antibody
Formatmab
Target NameTSC2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TSC2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2180-Ag-1Recombinant multi-species TSC2/ LAM/ PPP1R160 protein


    Target information

    Target IDGM-IP2180
    Target NameTSC2
    Gene ID7249,22084,24855,694965,479883,101082969,504985,100065679
    Gene Symbol and SynonymsLAM,Nafld,PPP1R160,Rc,Tcs2,TSC2,TSC4
    Uniprot AccessionP49815,P49816
    Uniprot Entry NameTSC2_HUMAN,TSC2_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000103197
    Target ClassificationTumor-associated antigen (TAA)

    The target: TSC2, gene name: TSC2, also named as LAM, PPP1R160, TSC4. This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.